[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Stitham et al., 2003 - Google Patents

The unique ligand-binding pocket for the human prostacyclin receptor: site-directed mutagenesis and molecular modeling

Stitham et al., 2003

View HTML @Full View
Document ID
12721551534068789706
Author
Stitham J
Stojanovic A
Merenick B
O'Hara K
Hwa J
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

The human prostacyclin receptor is a seven-transmembrane α-helical G-protein coupled receptor, which plays important roles in both vascular smooth muscle relaxation as well as prevention of blood coagulation. The position of the native ligand-binding pocket for …
Continue reading at www.jbc.org (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay

Similar Documents

Publication Publication Date Title
Stitham et al. The unique ligand-binding pocket for the human prostacyclin receptor: site-directed mutagenesis and molecular modeling
Weichert et al. Covalent agonists for studying G protein-coupled receptor activation
Hwa et al. The Unique Nature of the Serine Interactions for α1-Adrenergic Receptor Agonist Binding and Activation (∗)
Song et al. The Difference between the CB1 and CB2Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2
Gong et al. Structural basis for the recognition of Sonic Hedgehog by human Patched1
Song et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators
Asada et al. Crystal structure of the human angiotensin II type 2 receptor bound to an angiotensin II analog
Yamano et al. Mutagenesis and the Molecular Modeling of the Rat Angiotensin II Receptor (AT1)∗
Christopher et al. Biophysical fragment screening of the β1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design
Shimamura et al. Structure of the human histamine H1 receptor complex with doxepin
Janz et al. Direct interaction between an allosteric agonist pepducin and the chemokine receptor CXCR4
Kniazeff et al. No Ligand Binding in the GB2 Subunit of the GABABReceptor Is Required for Activation and Allosteric Interaction between the Subunits
Lee et al. Two defective heterozygous luteinizing hormone receptors can rescue hormone action
Fay et al. Cysteine residues in the human cannabinoid receptor: only C257 and C264 are required for a functional receptor, and steric bulk at C386 impairs antagonist SR141716A binding
Pei et al. Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation
Qu et al. Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E2 receptor EP2 subtype
Perlman et al. A Disulfide Bond between Conserved Extracellular Cysteines in the Thyrotropin-releasing Hormone Receptor Is Critical for Binding (∗)
Nagiri et al. Cryo-EM structure of the β3-adrenergic receptor reveals the molecular basis of subtype selectivity
Chen et al. Phe310 in transmembrane VI of the α1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding
Souza et al. Identification of a new hormone-binding site on the surface of thyroid hormone receptor
Nagiri et al. Crystal structure of human endothelin ETB receptor in complex with peptide inverse agonist IRL2500
Gomez-Soler et al. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling
Loo et al. Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites
Wu et al. Probing the correlation between ligand efficacy and conformational diversity at the α1A-adrenoreceptor reveals allosteric coupling of its microswitches
Ruan et al. Solution structure of the second extracellular loop of human thromboxane A2 receptor